Seattle Genetics is growing at a rate that other companies have not seen before because their cancer drugs are working better than others. They are an amazing company that has already created two cancer drugs, and they are clearing nearly $100 million in sales in a year due to the success of their drug trials. Doctors will buy up the drugs that work, and Clay Siegall wants the company to find more chances to expand what it offers. It might go into new cancer drugs, or it could expand with the drugs it already has.
Their stock price was indicated in a conference call transcript, and the stock price shows that they are doing well on the NASDAQ. This makes them a much more profitable company, and it brings them more cash that they can use to create new kinds of drugs. It is very easy for people to get well when they have strong companies like Seattle Genetics working on their cancer drugs, and it is even more important that doctor keep trusting this brand.
Clay Siegall is keeping the company on an even keel as they are trying to find new buyers for their drug lines. He wants the company to stay focused on what they are producing currently until they have enough money to move on to other drugs.
Someone who is trying to get well in a hospital or working with a trial doctor is already familiar with how Seattle Genetics works. They have seem the power that the company has given people to heal, and it is very helpful for people who need some hope. That makes it a lot easier for people to recover, and sometimes the trials are done when people do not have any other options to get better. Seattle Genetics is increasing how much money they are making every year because they are offering a better drug than the competition. They are showing that their new cancer drugs can help anyone.